Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 3/20 | 0.37 |
| ▸ | MAOA | P21397 | 1/20 | 0.37 |
| ▸ | GRM5 | P41594 | 2/20 | 0.32 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.31 |
| ▸ | VHL | P40337 | 1/20 | 0.30 |
| ▸ | ELOC | Q15369 | 1/20 | 0.30 |
| ▸ | ELOB | Q15370 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL67615 | 0.82 | MEN1 (0.46) | MAOBMAOAGRM5NOTUMVHL | |
| SCHEMBL30543406 | 0.82 | MEN1 (0.46) | MAOBMAOAGRM5NOTUMVHL | |
| SCHEMBL10741838 | 0.79 | SIRT2 (0.44) | MAOBMAOAGRM5NOTUMVHL | |
| SCHEMBL8191575 | 0.76 | MAOB (0.37) | MAOBMAOAGRM5VHLELOC | |
| SCHEMBL6582780 | 0.76 | MAPT (0.39) | MAOBMAOAGRM5 | |
| SCHEMBL29222599 | 0.76 | MAOB (0.34) | MAOBMAOAGRM5 | |
| SCHEMBL11483580 | 0.74 | GRM5 (0.40) | MAOBMAOAGRM5MEN1KMT2A | |
| Hydrochloric Acid SCHEMBL7401466 | 0.73 | MAPT (0.38) | MAOBMAOAGRM5 | |
| SCHEMBL7401468 | 0.72 | MAPT (0.37) | MAOBMAOAGRM5 | |
| SCHEMBL768960 | 0.71 | MAPT (0.46) | MAOBMAOAGRM5NOTUM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8129447-B2 | Ink composition and inkjet recording method using the same | FUJIFILM CORPORATION (JP) | 2012-03-06 | — | — | US | disclosed |
| US-20100285232-A1 | PROCESS FOR PRODUCING AN OVERPRINT | FUJIFILM CORPORATION (JP) | 2010-11-11 | — | — | US | disclosed |
| US-20090087575-A1 | INK COMPOSITION AND INKJET RECORDING METHOD USING THE SAME | FUJIFILM CORPORATION (JP) | 2009-04-02 | — | — | US | disclosed |
| WO-2000021949-A1 | QUINOLONES AS T-RNA SYNTHETASE INHIBITORS AND ANTIBACTERIAL AGENTS | SMITHKLINE BEECHAM PLC (GB) | 2000-04-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090087575-A1 | INK COMPOSITION AND INKJET RECORDING METHOD USING THE SAME | RB1, IK, NOX1 | MAOB 202/4885MAOA 415/4885GRM5 2547/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.